title: Should Avastin be used to treat age-related macular degeneration in the NHS?--Yes.
authors.affiliation: Wessex Institute, School of Medicine, University of Southampton, Southampton, UK. j.p.raftery@soton.ac.uk
authors.forename: J
authors.initials: J
authors.lastname: Raftery
authors.forename: L
authors.initials: L
authors.lastname: Dent
mesh_terms: D020533:Angiogenesis Inhibitors / Q000191:economics / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000191:economics / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D016527:Drug Costs; D006801:Humans; D008268:Macular Degeneration / Q000188:drug therapy* / Q000191:economics; D000069579:Ranibizumab; D013222:State Medicine
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D000069579:Ranibizumab